Concepedia

Author

Brian Van Ness

University of Minnesota

Also Known As

B Van Ness, B. Van Ness, Brian Van Ness, Brian Van ness, Brian van Ness, Ingemar Turesson, Van Ness, Brian,  B Van Ness

140

Publications

7.8K

Citations

43

H-Index

101

Concepts

All Affiliations

University of MinnesotaMayo Clinic in ArizonaMayo ClinicDana-Farber Cancer InstituteInstitut thématique Génétique, génomique et bioinformatique
BV

About

Brian Van Ness is an author at University of Minnesota specializing in medicine, cell biology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

25

1.8K

2

Health Sciences

4

4

241

3

Engineering

2

2

68

4

Education

1

1

16

5

Language Studies

1

1

11

Brian Van Ness

×

70

Publications

5.6K

Citations

39

H-Index

YearCitations

Clinical and biologic implications of recurrent genomic aberrations in myeloma

Rafaël Fonseca, Emily Blood, Montserrat Rué,

Blood

2003

658

Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation

Brian G.M. Durie, Robert A. Kyle, Andrew R. Belch,

The Hematology Journal

2003

423

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients

Rafaël Fonseca, Emily Blood, Martin M. Oken,

Blood

2002

337

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell.

Daniel D. Billadeau, Gregory Ahmann, Patricia T. Greipp,

The Journal of Experimental Medicine

1993

241

Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial

P Liu, Traci Leong, Lois Quam,

Blood

1996

224

Plasmablastic Morphology—An Independent Prognostic Factor With Clinical and Laboratory Correlates: Eastern Cooperative Oncology Group (ECOG) Myeloma Trial E9486 Report by the ECOG Myeloma Laboratory Group

Philip R. Greipp, Traci Leong, John M. Bennett,

Blood

1998

213

Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.

Rafaël Fonseca, David Harrington, Martin M. Oken,

PubMed

2002

182

Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients

Daniel D. Billadeau, Lois Quam, William K. Thomas,

Blood

1992

174

The polycomb group protein enhancer of zeste homolog 2 (EZH2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype

Paula Croonquist, Brian Van Ness

Oncogene

2005

156

RETRACTED: Downstream effectors of oncogenic ras in multiple myeloma cells

Liping Hu, Yijiang Shi, Jung-hsin Hsu,

Blood

2003

143

Page 1